Arrowhead Pharmaceuticals (STU:HDP1) Ending Cash Position : €117.49 Mil (As of Mar. 2024)

View and export this data going back to 1997. Start your Free Trial

What is Arrowhead Pharmaceuticals Ending Cash Position?

Arrowhead Pharmaceuticals's Ending Cash Position for the quarter that ended in Mar. 2024 was €117.49 Mil.

Arrowhead Pharmaceuticals's quarterly Ending Cash Position declined from Sep. 2023 (€103.91 Mil) to Dec. 2023 (€53.38 Mil) but then increased from Dec. 2023 (€53.38 Mil) to Mar. 2024 (€117.49 Mil).

Arrowhead Pharmaceuticals's annual Ending Cash Position declined from Sep. 2021 (€156.77 Mil) to Sep. 2022 (€109.09 Mil) and declined from Sep. 2022 (€109.09 Mil) to Sep. 2023 (€103.91 Mil).

Arrowhead Pharmaceuticals Ending Cash Position Historical Data

The historical data trend for Arrowhead Pharmaceuticals's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Arrowhead Pharmaceuticals Ending Cash Position Chart

Arrowhead Pharmaceuticals Annual Data

Trend

Sep14

Sep15

Sep16

Sep17

Sep18

Sep19

Sep20

Sep21

Sep22

Sep23

Ending Cash Position

Get a 7-Day Free Trial

201.40

121.90

156.77

109.09

103.91

Arrowhead Pharmaceuticals Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Ending Cash Position	Get a 7-Day Free Trial															126.05	97.22	103.91	53.38	117.49

Arrowhead Pharmaceuticals Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Arrowhead Pharmaceuticals's Ending Cash Position for the fiscal year that ended in Sep. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	101.2	+	2.705
	=	103.91

Arrowhead Pharmaceuticals's Ending Cash Position for the quarter that ended in Mar. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	53.558	+	63.93
	=	117.49

Arrowhead Pharmaceuticals Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Arrowhead Pharmaceuticals's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Arrowhead Pharmaceuticals (STU:HDP1) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Arrowhead Pharmaceuticals Inc (STU:HDP1) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

ARWR:USA

Address

177 E. Colorado Boulevard, Suite 700, Pasadena, CA, USA, 91105

Website

https://www.arrowheadpharma.com

Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting hepatitis B, Alpha-1 Antitrypsin Deficiency, thrombosis and angioedema, clear-cell and renal cell carcinoma, and cardiovascular disease.

Arrowhead Pharmaceuticals (STU:HDP1) Headlines

No Headlines